Human chorionic gonadotropin biosimilar (Ferring)

重组人绒毛膜促性腺激素（辉凌）

Report date: 2022/12/23 14:25:28

Base Information

Drug NameHuman chorionic gonadotropin biosimilar (Ferring)
Drug Alias NameChoriogonadotropin subunit beta(Ferring)人绒毛膜促性腺激素生物类似药（辉凌）hCG follow-on biologic(Ferring)绒促性素β（辉凌）human chorionic gonadotropin(Ferring) +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonistsFollicle-stimulating hormone receptor agonists
TargetsLuteinizing hormone/Choriogonadotropin receptorFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility
Global Approved IndicationsInfertility
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1974/01/15
Country/TerritoryUnited StatesSpainMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaIND
Originator CompaniesFerring Bv
China Registration ClassN/A

Develop Information

Active CompaniesFerring BvFerring Pharmaceutical Consulting (Shanghai) Co Ltd
Inactive CompaniesUniversity Of California San Francisco
Active IndicationsInfertility
Inactive IndicationsN/A

Other Information

ATC CodeG03GA01
Related LinksN/A